Transparency Market
Research (TMR) has published a new report titled, ‘Cytology and HPV Testing Market - Global Industry Analysis, Size, Share,
Growth, Trends, and Forecast, 2019–2027’. According to the
report, the global cytology and HPV
testing market was valued at US$ 7.42 Bn in 2018 and is projected
to expand at a CAGR of 5.9% from 2019 to 2027.
Overview
·
Human papillomavirus (HPV) test is usually performed to
determine high risk of HPV infection, which might cause formation of cancerous
cells on the cervix
·
Factors such as emergence of highly sensitive and
specific assays and advanced analyzing instruments drive the market for HPV
testing for cervical cancer screening. Moreover, escalating incidence rate of
high-risk types of HPV is likely to boost the HPV testing market in the near
future.
·
However, accuracy of test outcomes and disadvantages of
the HPV test including low specificity are some of the factors that are
anticipated to restrain growth of the HPV testing segment
·
Increasing incidence of HPV infections and cervical
cancer and weakening immune system of the population drive the global cytology
and HPV testing market. This trend is expected to continue during the forecast
period.
·
Additionally, growing awareness and technological
advancements in health care are encouraging people to opt for high accuracy
diagnostic tests. All the above-mentioned factors are anticipated to boost the growth
of the cytology and HPV testing market.
·
Various collaborations, partnerships, and acquisitions
have been carried out by top market players to develop innovative diagnostic
tests kits and instruments
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2216
Rising Incidence of Cervical Cancer Worldwide to Drive Market
·
As per various research studies conducted by the Centers
for Disease Control and Prevention, the number of new cases of cervical cancer
patients and the number of deaths due to cervical cancer have decreased
significantly in the past 40 years i.e., between 1955 and 1992, the cervical
cancer death rate declined by almost 70% in U.S.
·
According to the American Cancer Society, cervical cancer
is one of the most common causes of cancer death for in women in the U.S. In
addition, according to the organization, it has been estimated that
approximately 12,990 women in
the U.S. would be diagnosed with cervical cancer and 4,120 deaths would occur from this disease in 2016
·
The decline in death rate is attributed to factors such
as increased use of Pap screening test and growing awareness among cervical
cancer patients about screening tests available commercially in the market and
the offered benefits for disease prevention
·
Thus, increasing incidence of cervical cancer is likely
to boost the cytology and HPV testing market during the forecast period
Request for Analysis
of COVID19 Impact on Cytology and HPV Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2216
Cytology Testing Segment to Dominate Market
·
Based on product type, the global cytology and HPV
testing market has been divided into HPV testing and cytology testing segment
·
Cytology testing segment held the largest share of the
market in 2018 due to high
number of PAP tests performed across the globe
·
Factors such as increasing demand of highly sensitive
cytology kits, increasing demand for innovative and highly accurate diagnostic
kits and affordable price of the test kits are likely to drive the cytology
assay kits segment from 2019 to 2027
Purchase
Cytology and HPV Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=2216<ype=S
North America to Dominate Global Market
·
In terms of region, the global cytology and HPV testing
market has been segmented into North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa. North America dominated the global
cytology and HPV testing market in 2018, followed by
Europe.
·
The dominance of this region is due to increase in the
incidence of cervical cancer, HPV infections, and rising number of awareness
programs initiated by governments regarding availability of technologically
advanced diagnostic test kits
·
In addition, the market in North America show high growth
of the HPV testing market. New FDA guidelines will lead to increase in HPV
tests as a primary screening, along with co-testing with PAP.
Competitive Landscape
·
The global cytology and HPV Testing market is largely
consolidated, with top 5 players accounting for major market share. Key players
in the global market Becton, Dickinson and
Company, Cepheid, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG,
Fujirebio Diagnostics, Inc., Arbor Vita Corporation, Hologic, Inc., QIAGEN
N.V., and OncoHealth Corporation
More Trending Reports by
Transparency Market Research:
https://www.prnewswire.com/news-releases/technological-advancements-and-innovations-to-fuel-growth-of-soft-tissue-repair-market-from-2018-to-2026-tmr-301168624.html
https://www.prnewswire.com/news-releases/global-oral-contraceptive-pills-market-projected-to-expand-at-6-cagr-rising-number-of-unplanned-pregnancies-drives-market-demand-tmr-301171827.html
About Us
Transparency Market Research
is a global market intelligence company, providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for thousands of decision
makers. Our experienced team of analysts, researchers, and consultants, uses
proprietary data sources and various tools and techniques to gather and analyze
information.
Our data repository is
continuously updated and revised by a team of research experts, so that it
always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and
secondary research techniques in developing distinctive data sets and research
material for business reports.
Contact
Transparency Market
Research,
90 State Street, Suite
700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com/
